Welcome to our dedicated page for ENSIGN GROUP SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (ENSG) filings document its public-company reporting as a Delaware healthcare services company with common stock listed on the Nasdaq Global Select Market. Its disclosures cover skilled nursing and senior living operations, therapy and rehabilitative services, healthcare real estate, and the Standard Bearer real estate segment.
Ensign’s 8-K reports disclose quarterly and annual operating results and Regulation G non-GAAP measures, including adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA, adjusted EBITDAR, adjusted EBT, and Funds from Operations for its real estate segment. Proxy materials cover shareholder voting, board governance, executive compensation, equity awards, capital-structure matters, and other governance disclosures.
Ensign Group, Inc. director John O. Agwunobi sold 392 shares of common stock on July 20, 2026 at $171.06 per share in an open market or private transaction. The sale was executed under a Rule 10b5-1 trading plan adopted on July 31, 2025. After this trade, he directly owns 9,503.149 shares.
Ensign Group Inc. insider John O. Agwunobi submitted a notice of proposed sale of common stock. The notice covers up to 392 common shares to be sold through Fidelity Brokerage Services LLC on NASDAQ on 07/20/2026, with an indicated aggregate value of $67,055.52.
The disclosure also notes restricted stock vesting events from the issuer as compensation, including 246 shares on 07/15/2026 and 146 shares on 07/17/2026. Over the prior three months, Agwunobi sold 392 common shares on 04/20/2026 for $78,388.24.
SMITH BARRY M reported acquisition or exercise transactions in this Form 4 filing.
Ensign Group, Inc. director Barry M. Smith reported an equity grant of 600 shares of Common Stock on July 15, 2026. The award was granted at $0.00 per share and vests in three equal annual installments beginning July 15, 2027, bringing his directly held shares to 21,952.
Ensign Group director Daren Shaw received a grant of 600 shares of Common Stock on July 15, 2026, reported as a grant/award acquisition. These shares vest in three equal annual installments beginning July 15, 2027. After this award, he directly holds 24,926 shares.
Blouin Ann Scott reported acquisition or exercise transactions in this Form 4 filing.
Ensign Group, Inc. director Ann Scott Blouin reported receiving a 600-share grant of common stock on July 15, 2026. The shares were awarded at $0.00 per share and vest in three equal annual installments beginning July 15, 2027, bringing her direct holdings to 24,052 shares.
Abbott Swati Bargotra reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director Swati Bargotra Abbott received an equity award of 600 shares of Common Stock on July 15, 2026. The shares were granted at no cost and vest in three equal annual installments beginning July 15, 2027. Following this award, Abbott directly holds 20,832 shares.
Agwunobi John O reported acquisition or exercise transactions in this Form 4 filing.
ENSIGN GROUP, INC director John O. Agwunobi received an equity grant of 600 shares of Common Stock on July 15, 2026, recorded at a stated price of $0.00 per share. These shares vest in three equal annual installments beginning July 15, 2027. Following the award, he directly holds 9,895.1490 shares.
ENSIGN GROUP, INC director Mark Vincent Parkinson reported two Common Stock transactions. On July 15, 2026, he received a grant of 600 shares at no cost, which vest in three equal annual installments beginning July 15, 2027, increasing his direct holdings to 4,000 shares. On July 16, 2026, he sold 100 shares at $168.12 per share in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025, leaving him with 3,900 shares held directly.
Mark Parkinson filed a notice to sell up to 100 shares of ENSG common stock through Fidelity Brokerage Services LLC, with a proposed sale date of 07/16/2026 and an aggregate value of 16,812.00. These shares vested as restricted stock from the issuer on 07/15/2026. During the past three months, he sold 100 common shares on 04/16/2026 for an aggregate value of 19,660.00.
The Ensign Group, Inc. announced that its board approved a $60 million increase to its previously authorized $40 million stock repurchase program, raising total buyback capacity to $100 million. Repurchases may occur in open‑market and privately negotiated transactions, including under Rule 10b‑18 and Rule 10b5‑1 plans.
The program is discretionary, with no obligation to repurchase a specific amount, and can be modified, suspended or discontinued at any time. Management highlights strong financial performance and a focus on disciplined capital allocation as it prepares to commence repurchases under the expanded authorization in the near term.